marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Aziyo Biologics Financial Ratios 2011-2024 | AZYO
Annual Financial Ratios Aziyo Biologics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.7 | -1.7 | -2.6 | -7.6 | - | - | - | - | - | - | - | - | - |
P/S |
1.1 | 2.4 | 1.4 | 3.9 | - | - | - | - | - | - | - | - | - |
EPS |
-2.1 | -2.4 | -2.4 | -8.9 | -18.5 | - | - | - | - | - | - | - | - |
EV (Enterprise Value) |
89.6 M | 114 M | 89.1 M | 188 M | 97.3 M | 91.1 M | - | - | - | - | - | - | - |
EBITDA per Share |
-1.47 | -2.27 | -1.85 | -0.952 | - | - | - | - | - | - | - | - | - |
EV/EBITDA |
-4.5 | -16.1 | - | - | - | - | - | - | - | - | - | ||
PEG |
- | 0.09 | - | - | - | - | - | - | - | - | - | ||
P/B |
-0.7 | -11.3 | 4.9 | 7.9 | - | - | - | - | - | - | - | - | - |
P/CF |
-1.2 | -2.6 | -4.3 | -11.6 | - | - | - | - | - | - | - | - | - |
ROE % |
97.55 | 653.63 | -183.66 | -104.77 | - | - | - | - | - | - | - | - | - |
ROA % |
-86.71 | -47.79 | -36.97 | -26.36 | - | - | - | - | - | - | - | - | - |
ROCE % |
79.08 | 699.17 | -170.34 | -24.27 | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.5 | 0.9 | 1.3 | 2.2 | - | - | - | - | - | - | - | - | - |
DSO |
51.9 | 74.8 | 50.7 | 61.3 | - | - | - | - | - | - | - | - | - |
DIO |
107.9 | 206.2 | 126.5 | 166.9 | - | - | - | - | - | - | - | - | - |
DPO |
48.8 | 44.2 | 23.4 | 33.9 | - | - | - | - | - | - | - | - | - |
Operating Cycle |
159.8 | 280.9 | 177.2 | 228.2 | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
111.0 | 236.8 | 153.8 | 194.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Aziyo Biologics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
0.03 | -1.13 | -0.75 | -0.57 | -0.65 | -0.49 | - | -0.73 | -0.69 | -0.6 | - | -0.81 | -0.23 | -0.5 | - | -15.79 | -7.99 | -7.03 | - | -4.81 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.29 | -0.31 | -0.32 | -0.38 | -0.34 | -0.46 | - | -0.59 | -0.54 | -0.44 | - | -0.41 | -0.27 | -0.27 | - | 0.35 | -2.8 | -3.41 | - | 1.61 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
109.45 | 160.64 | 182.34 | 239.35 | 299.06 | 937.54 | 655.03 | 549.21 | 350.62 | -351.81 | -152.56 | -184.88 | -111.37 | -120.30 | -79.06 | -73.43 | -35.48 | -10.63 | 5.63 | 5.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-133.34 | -156.29 | -102.19 | -67.55 | -65.93 | -63.41 | -47.62 | -61.50 | -59.14 | -44.79 | -24.13 | -32.26 | -26.51 | -29.34 | -19.89 | -26.82 | -25.63 | -19.37 | -6.93 | -6.93 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
80.52 | 83.60 | 138.87 | 205.97 | 264.91 | 834.06 | 576.08 | 487.32 | 314.60 | -313.76 | -141.96 | -154.88 | -79.03 | -66.40 | -46.26 | -42.91 | -26.64 | -8.57 | 3.35 | 3.35 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
0.6 | 0.4 | 0.4 | 0.7 | 0.7 | 0.8 | 0.9 | 0.8 | 1.0 | 1.1 | 1.2 | 1.1 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 0.8 | 0.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
49.7 | 57.5 | 49.7 | 68.5 | 98.1 | 101.1 | - | 107.7 | 45.7 | 47.6 | - | 52.7 | 62.0 | 56.4 | - | 55.5 | 76.2 | 66.6 | - | 29.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
96.8 | 80.6 | 113.2 | 219.1 | 255.0 | 319.1 | - | 311.9 | 115.3 | 122.8 | - | 118.1 | 143.3 | 141.5 | - | 148.1 | 192.5 | 169.9 | - | 58.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
117.8 | 95.3 | 84.3 | 85.9 | 84.4 | 88.1 | - | 68.7 | 20.5 | 20.9 | - | 19.4 | 25.1 | 28.0 | - | 30.1 | 39.1 | 44.6 | - | 20.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
146.5 | 138.1 | 162.9 | 287.6 | 353.1 | 420.2 | - | 419.6 | 161.0 | 170.4 | - | 170.8 | 205.2 | 197.9 | - | 203.7 | 268.8 | 236.5 | - | 88.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
28.7 | 42.7 | 78.5 | 201.6 | 268.7 | 332.1 | - | 350.9 | 140.5 | 149.6 | - | 151.3 | 180.1 | 169.9 | - | 173.6 | 229.7 | 191.9 | - | 67.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency